Elligo Health Research, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Elligo Health Research, Inc. - overview
Established
2016
Location
Austin, TX, US
Primary Industry
Biotechnology
About
Founded in 2016 and based in Texas, US, Elligo Health Research, Inc. is a medical research company that uses healthcare data to find and identify eligible physicians and patients for clinical trials. Mr. Chad Moore founded the company and has raised four venture capital financing from private equity investors, including Noro-Moseley Partners, Hatteras Venture Partners, and Excelerate Health Ventures.
In September 2021, Morgan Stanley Expansion Capital and Ally Bridge Group co-led a USD 135 million in Series E funding for Elligo Health Research, Inc. The company offers the Goes Direct approach and novel IntElligo Research Stack, a platform that identifies and provides a diverse population for clinical trials and research on new pharmaceutical, biotechnology, medical device, and diagnostic products. The platform also enables physicians to access over 150 million patients and their data through a platform that executes traditional site-based, hybrid, and decentralized clinical trial models. Elligo Health Research, Inc.
plans to use the September 2021 funding to acquire ClinEdge and invest further in the company's technology and data platform.
Current Investors
Noro-Moseley Partners, Hatteras Venture Partners, Excelerate Health Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Pharmaceutical Research & Development
Website
www.elligohealthresearch.com
Company Stage
Series E
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.